Universitätsklinikum Köln

uk-koeln.de

Total trials

33

Active

2

Phase 3

1

Total enrollment

10,473

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 0 of 0 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal

Next readouts

No upcoming readouts found.

Top conditions

  • Ventricular Tachycardia3
  • Cardiac Arrest2
  • ICD Malfunction2
  • Implantable Defibrillator User2
  • Hypoxia, Altitude2
  • Sudden Cardiac Death2
  • Multiple Trauma2
  • PVC - Premature Ventricular Complex2

Frequently asked questions about Universitätsklinikum Köln

How many clinical trials does Universitätsklinikum Köln have on ClinicalTrials.gov?
Universitätsklinikum Köln is listed as the lead sponsor on 33 clinical trials in ClinicalTrials.gov, 2 of which are currently active (recruiting, enrolling, or ongoing).
How many of Universitätsklinikum Köln's trials are in Phase 3?
1 of Universitätsklinikum Köln's trials are in Phase 3.
What therapeutic areas does Universitätsklinikum Köln focus on?
Universitätsklinikum Köln's most-studied conditions on ClinicalTrials.gov are Ventricular Tachycardia, Cardiac Arrest, ICD Malfunction, Implantable Defibrillator User, Hypoxia, Altitude.